HIV and antiretroviral therapy in the brain: neuronal injury and repair

@article{Ellis2007HIVAA,
  title={HIV and antiretroviral therapy in the brain: neuronal injury and repair},
  author={Ronald J. Ellis and Dianne Langford and Eliezer Masliah},
  journal={Nature Reviews Neuroscience},
  year={2007},
  volume={8},
  pages={33-44}
}
Approximately 40 million people worldwide are infected with human immunodeficiency virus (HIV). Despite HIV's known propensity to infect the CNS and cause neurological disease, HIV neurocognitive disorders remain under-recognized. Although combination antiretroviral therapy has improved the health of millions of those living with HIV, the penetration into the CNS of many such therapies is limited, and patients' quality of life continues to be diminished by milder, residual neurocognitive… Expand
Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction
TLDR
Combination therapies that lower CNS viral load and improve immune homeostasis and neuroprotection will be required to address the neuropathogenesis of HIV infection. Expand
HIV-associated synaptic degeneration
TLDR
Identifying the specific mechanism of the synaptic degeneration may facilitate the development of effective therapeutic approaches to treat HIV-associated neurocognitive disorders (HAND). Expand
HIV-Associated Neurocognitive Disorders
TLDR
Treatments that can perturb the viral reservoirs and decrease chronic inflammatory response, in addition to continuing cART, may give the clinician additional tools to prevent HAND. Expand
Assessing the contribution of antiretroviral therapy to neuronal damage and death as a mediator of cognitive decline in HIV-associated neurocognitive disorders
The advent of combination antiretroviral therapy (ART) in 1996 revolutionized the treatment of HIV/AIDS and significantly decreased the incidence of HIV-associated neurocognitive disorders (HAND), aExpand
Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap
TLDR
This review attempts to answer why there appears to be a therapeutic gap between the salutary effects of antiretroviral regimens and normalization of neurological function, and discusses the animal models that have helped to elucidate these mechanisms. Expand
Synaptic dysfunction in human immunodeficiency virus type‐1‐positive subjects: inflammation or impaired neuronal plasticity?
TLDR
Experimental evidence is presented that some of the clinical features of HIV‐mediated neurological impairment could result from altered BDNF/TrkB/p75NTR regulation and function. Expand
Pathogenesis of HIV in the Central Nervous System
TLDR
This review highlights recent investigations of HIV-related CNS injury with emphasis on cART-era neuropathological mechanisms in the context of both US and international settings. Expand
NeuroAIDS: An Evolving Epidemic
TLDR
Clinical presentations, underlying pathogenesis and treatments of HIV-induced neurological disorders, a burgeoning group of neurological disorders that include opportunistic infections in addition to distinct HIV-associated neurological syndromes, are reviewed. Expand
Human Immunodeficiency Virus Promotes Mitochondrial Toxicity
TLDR
This review aims to outline the many targets and pathways used by viral proteins to alter mitochondria dynamics, which contribute to HIV-induced neurotoxicity. Expand
HIV-Proteins-Associated CNS Neurotoxicity, Their Mediators, and Alternative Treatments.
  • Adonira Saro, Zhaolin Gao, +14 authors Jufang Huang
  • Medicine
  • Cellular and molecular neurobiology
  • 2021
TLDR
The purpose of this review is to provide a synopsis of the effects of these proteins on the central nervous system and conceptualize avenues to be considered in mitigating HAND, and simulate the transcription factors that bind to the promoter of the HIV-1 protein and possibly could be used as a target to circumvent HIV-associated neurocognitive disorders. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 179 REFERENCES
Mechanisms of Neuroimmunity and Neurodegeneration Associated with HIV-1 Infection and AIDS
TLDR
Recently uncovered pathologic neuroimmune and degenerative mechanisms contributing to neuronal damage induced by HIV-1 are addressed and experimental and potentially future therapeutic approaches are discussed. Expand
Pathways to neuronal injury and apoptosis in HIV-associated dementia
TLDR
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide, but discovery in brain of HIV-1-binding sites (chemokine receptors) provides new insights. Expand
Neuroprotective therapy for HIV dementia.
TLDR
All the placebo controlled clinical trials conducted to date with neuromodulatory/neuroprotective therapy in patients with HIV dementia are reviewed and a thorough review of potential new treatments for HIV dementia based on the experimental literature is provided. Expand
The neuropathogenesis of AIDS
TLDR
The studies that are being carried out to determine the respective contributions of infection, and monocyte and macrophage activation, to disease progression are discussed. Expand
Neuroprotective Strategies for HIV‐1‐Associated Neurologic Disease
  • H. Gelbard
  • Medicine
  • Annals of the New York Academy of Sciences
  • 1999
TLDR
In vitro models are used to identify novel relationships between several HIV-1 neurotoxins that may be critical to inducing disruption of normal neuronal functions and ultimately causing neuronal apoptosis, and to demonstrate that marked upregulation of the pro-apoptotic gene product caspase 3 occurs in neurons in pediatric patients with HIV- 1-associated neurologic disease. Expand
Simian Immunodeficiency Virus: A Model for NeuroAIDS
TLDR
The profile of the infection and the host response, and the resulting cognitive, motor, and neurophysiological abnormalities in SIV-infected monkeys, recapitulates many aspects of the functional impairments associated with HIV-induced CNS disease in humans. Expand
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.
  • A. Nath
  • Biology, Medicine
  • The Journal of infectious diseases
  • 2002
TLDR
Future therapeutic strategies must target common mechanisms such as oxidative stress and dysregulation of intracellular calcium involved in virotoxin-mediated neurotoxicity involved in HIV infection of the nervous system. Expand
Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders
TLDR
It appears that even milder neurocognitive impairment reflects microneuroanatomical injury to synaptic structures. Expand
Early penetration of the blood‐brain‐barrier by HIV
TLDR
It is indicated that HIV infects the CNS early in the course of viral infection and prior to the development of HIV-associated neurologic abnormalities. Expand
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection
TLDR
Findings suggest that resurgence of active HIV replication may result in measurable, albeit subclinical, CNS injury and further studies are needed to define the frequency and pathobiological importance of the increase in CSF NFL. Expand
...
1
2
3
4
5
...